Clinical Trial Update: Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a 5-fluorouracil–based regimen in combination with Fruquintinib for metastatic colorectal cancer; the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-fluorouracil (5-FU) (5-fluorouracil)
• Fruquintinib (fruquintinib)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Metastatic Colorectal Cancer (CRC) | Phase 2 | Status: RECRUITING